Background: There is growing interest in utilizing community pharmacies to support opioid abuse prevention and addiction treatment efforts. However, it is unknown whether the placement of community pharmacies is conducive to taking on such a role. Objective: To examine the distribution of community pharmacies in Wisconsin and its relationship with the location of addiction treatment facilities and opioid-related overdose events in rural and urban areas. Methods: The total number of opioid-related overdose deaths and crude death rates per 100,000 population were determined for each county in Wisconsin. Substance abuse treatment facilities were identified in each county to estimate access to formal addiction treatment. A list of pharmacies in the state was screened to identify community pharmacies in each county. Descriptive statistics and Pearson correlation coefficients were used to describe the distribution of and relationships between county-level opioid-related overdose death rates and the number of treatment facilities and community pharmacies in the state. Results: Wisconsin has 72 counties, of which 45 (62.5%) are classified as rural. Although the number of opioidrelated overdose deaths was highly concentrated in urban areas, crude death rates per 100,000 population were similar in urban and rural areas. Rural counties were significantly less likely to have formal substance abuse treatment facilities (r = −.42, P = .00) or community pharmacies (r = −.44, P = .00) compared to urban counties. However, community pharmacies were more prevalent and more likely to be located in rural counties with higher rates of opioid-related overdose deaths than substance abuse treatment facilities. All but 1 of the 14 counties without a formal substance abuse treatment facility had access to 1 or more community pharmacies. Conclusions: Community pharmacies are ideally located in areas that could be used to support medicationassisted addiction treatment efforts, particularly in rural areas lacking formal substance abuse treatment facilities.
Introduction
There has been a significant increase in the misuse and abuse of both illicit and prescription opioids, leading to rapid increases in drug overdoses and death rates. 1, 2 Rural areas have been hit particularly hard by the opioid epidemic. [3] [4] [5] Rural residents face challenges due to the lack of access to addiction treatment, an inadequate mental health workforce, and long travel times to access addiction treatment, leading to higher treatment costs. [6] [7] [8] While telehealth has shown promise as an alternative, cost-effective care option for individuals living in rural or remote areas, 6 there remain unmet personnel needs to supplement telehealth services for addiction treatment, particularly when it comes to medication-assisted treatment of opioid use disorders. Community pharmacies are an integral part of the rural health care system, as they are often the only formal access point for health care in smaller rural communities. 9 Pharmacies are increasingly taking on community and public health roles related to the opioid epidemic, such as creating prescription medication take-back programs to support safe medication disposal, and patient education in areas such as pain management, mental health, and substance abuse. 10, 11 Although current assessments of pharmacy's role in reducing opioid-related morbidity and mortality have focused on the use and impact of prescription drug monitoring programs, [12] [13] [14] [15] there is a growing movement to involve pharmacies in other public health activities such as naloxone dispensing and opioid safety counseling. [16] [17] [18] [19] [20] [21] opioid use disorders found that pharmacists working as clinical care managers was a key design factors among successful programs. 26 Since nearly 93% of US residents live within 5 miles of a pharmacy, 27 this may provide an opportunity for community pharmacies to support formal opioid abuse prevention and addiction treatment efforts, particularly in rural areas. However, it is unknown whether the placement of community pharmacies is conducive to taking on such a role. Therefore, the overall goal of this descriptive study was to examine the distribution of community pharmacies in Wisconsin and its relationship with the location of addiction treatment facilities and opioid-related overdose events in rural and urban areas. Data from the state of Wisconsin were used, as opioid-related overdose deaths are the leading cause of injury deaths in the state, and have more than tripled from 194 deaths in 2003 to 622 deaths in 2014. 28 In addition, over one-quarter of the population lives in a rural area. The information from this study will be useful to identify areas of unmet need for substance abuse treatment as well as potential opportunities to utilize community pharmacies as access points to support opioid abuse prevention and treatment efforts.
Methods

Data sources
County-level data for all opioid-related overdose deaths were obtained from the Wisconsin Department of Health Services for the year 2015, which was the most current and complete dataset available. The data included opioid-related overdose deaths identified by an ICD-10 code indicating drug poisoning as an underlying cause of death (X40-X44, X60-X64, X85, or Y10-Y14) and any of the following contributing cause of death codes: T400 (opium), T401 (heroin), T402 (natural and semisynthetic opioid), T403 (methadone), T404 (synthetic opioid other than methadone), or T406 (other and unspecified narcotic). 29 These data included the total number of deaths and crude death rates, which were calculated by dividing the total number of deaths in a county by the total population in the county and were defined as the death rate per 100,000 population. Each county was classified as rural or urban based on the 2013 Rural-Urban Continuum Codes obtained from the United States Department of Agriculture website. 30 A list of all addiction treatment facilities in the state was obtained from the Substance Abuse and Mental Health Services Administration (SAMHSA) website's behavioral health treatment services locator. 31 Available information included facility name, location, websites, and services provided. Only facilities classified as substance abuse treatment facilities (n = 199) by SAMHSA were included in the analysis.
A list of all pharmacies in the state was obtained from the Wisconsin Department of Safety and Professional Services. These data provide detailed information on the name and location of pharmacies licensed in the state of Wisconsin. Only pharmacies with active, in-state licenses were included in the evaluation. Information on CVS pharmacies was obtained using their website as they were not included in the original data file. A total of 1179 pharmacies in the state were identified and labeled by county using the registered 5-digit zip-code. Each pharmacy location was then manually screened by the study team to identify community pharmacy locations by name recognition, looking up pharmacies on the internet, and/or confirming the type of pharmacy by phone. 32, 33 Community pharmacies included independent, chain, clinic, hospital outpatient, and health maintenance organization pharmacies. Excluded pharmacy practice settings included hospital inpatient pharmacies, long term care pharmacies, and veterinary pharmacies.
Analysis
ArcGIS version 10.5 software was used to map and identify trends across counties regarding opioid-related overdose deaths, the locations of substance abuse treatment facilities, and community pharmacies in the state of Wisconsin using an approach similar to Burrell et al. (2017) . 16 Maps were constructed with the use of graduated quintile breaks of opioid-related overdose death rates per 100,000 population by county as the base layer, and were overlaid with the geocoded locations of substance abuse treatment facilities and community pharmacies. 34 Descriptive statistics and Pearson correlation coefficients were used to describe the distribution of and relationships between county-level opioid-related overdose death rates and the number of treatment facilities and community pharmacies in the state. Areas of interest included counties with high death rates and counties with limited access to formal addiction treatment. These analyses were conducted using Stata version 15.1. This study was considered exempt by the University of Wisconsin-Madison Institutional Review Board.
Results
Wisconsin has 72 counties, of which 27 (37.5%) are classified as urban and 45 (62.5%) as rural. A total of 611 opioid-related overdose deaths were reported in Wisconsin in 2015; however, the distribution of these deaths at the county level was highly skewed towards urban counties ( Table 1 ). The number of opioid-related overdose deaths per county ranged from 0 to 218, with a median of 1 death per county; approximately 25% of counties had 0 deaths, 25% had 1 death, and 50% had 2 or more deaths. The crude death rates were more consistent a Crude death rates were calculated by dividing the total number of deaths in a county by the total population in the county and were defined as the death rate per 100,000 population.
across counties, ranging from 0 to 23 deaths per 100,000 population, with a median of 5 deaths per 100,000. A strong relationship was seen between population size and the number of opioid-related overdose deaths, such that the highest population counties had the largest number of deaths (r = .94, P = .00) ( Table 2) . However, when deaths were evaluated as crude death rates per 100,000 population, this relationship was attenuated (r = .38, P = .00). Although a weak negative relationship was seen between rural status and the number of opioidrelated overdose deaths (r = −.32, P = .01), urban and rural counties had similar rates of opioid-related overdose deaths (r = −.20, P = .10). A total of 199 substance abuse treatment facilities were identified in Wisconsin, ranging from 0 to 29 per county, with a median of 2 per county ( Table 1, Fig. 1 ). Approximately 20% of counties (n = 14) had 0 facilities, 50% had 1-2 facilities, and 30% had 3 or more facilities. A strong relationship was also seen between population size and the number of substance abuse treatment facilities (r = .95, P = .00). In addition, rural counties were significantly less likely than urban counties to have formal substance abuse treatment facilities (r = −.42, P = .00), as approximately two-thirds of rural counties had either 0 or 1 facility.
Of the 1179 pharmacies that in the state, 941 pharmacies (79.8%) were identified as community pharmacies. The number of community pharmacies per county ranged from 0 to 152 pharmacies, with a median of 6 pharmacies per county (Table 1, Fig. 2 ). About one-third of Wisconsin counties had 3 or fewer community pharmacies, one-third had 4-10 pharmacies, and one-third had greater than 10 pharmacies. However, the distribution of community pharmacies in the state was highly skewed towards counties with higher populations (r = .99, P = .00), with a median of 16 pharmacies per county in urban areas and 4 pharmacies per county in rural areas. Similar to the relationship seen for substance abuse treatment facilities, rural counties were significantly less likely to have community pharmacies (r = −.44, P = .00); however, all but 1 rural county (Florence county) had at least 1 community pharmacy.
Strong positive relationships were seen between county population size and the numbers of opioid-related overdose deaths, substance abuse treatment facilities, and community pharmacies ( Table 2 ). In addition, there were strong positive relationships between the number of opioid-related overdose deaths with substance abuse treatment facilities (r = .89, P = .00) as well as with community pharmacies (r = .91, P = .00). These relationships were much smaller when death rates were used instead of the number of deaths (Table 2 ). In addition, there was a strong correlation between the location of treatment facilities and community pharmacies (r = .94, P = .00).
When the results were stratified by urban and rural location, slightly different patterns emerged. The relationships between these variables in urban areas were similar to those seen overall (Table 2) . However, more variability was seen in rural areas. Although population size was strongly related to the number of opioid-related overdose deaths (r = .71, P = .00) and community pharmacies (r = .91, P = .00), it was only weakly associated with the number of substance abuse treatment facilities (r = .36, P = .02). In contrast to urban areas, the relationships seen between the number of opioid-related deaths, treatment facilities, and community pharmacies were much lower in rural areas (Table 2) Of particular note was that the strength of the relationship between opioid-related overdose deaths with community pharmacies was nearly twice as high as the relationship with treatment facilities (r = .61, P = .00 vs r = .37, P = .01), which indicates community pharmacies were more likely to be located in rural counties with higher rates of opioid-related overdose deaths than substance abuse treatment facilities. In addition, a low to moderate correlation between community pharmacies and treatment facilities (r = .39, P = .01) suggests differential access to these types of organizations in rural counties. These findings contrast with urban areas, where there were strong correlations of similar size between opioid-related overdose deaths, treatment facilities, and community pharmacies, which indicates similar placement of these organizations in urban counties. All but 1 of the 14 counties in Wisconsin without any substance abuse treatment facilities had at least 1 community pharmacy, which ranged from 0 to 12 pharmacies. Thus, 1 or more community pharmacies were commonly located in counties with limited access to formal addiction treatment facilities.
Discussion
Several rural Wisconsin counties have been disproportionately affected by deaths due to opioids, 29 and there is limited access to addiction treatment facilities in many of these areas, which is not a problem unique to Wisconsin. 7, 8 While there is a growing interest in the utilization of telehealth services to address these gaps, 6 this approach has a limited ability to address key aspects of medication-assisted treatment including the dispensing, administration, and monitoring of medications. This is particularly relevant as the US Food and Drug Administration has recently expressed interested in broadening access to medication-assisted treatment for opioid addiction. 35 Although opioid-reported deaths were fairly rare at the county level, addiction treatment facilities may not always be located in the counties that have the most need of them, particularly in rural areas. Our findings suggest that community pharmacies may be ideally located in areas that could be used to support opioid treatment efforts in counties with limited or no access to formal addiction treatment facilities. All but 1 of the 14 Wisconsin counties lacking a formal substance abuse treatment facility had at least 1 community pharmacy, and often included multiple pharmacies. Utilizing community pharmacies in this way may enable rapid expansion and greater reach of addiction treatment efforts. In addition, this could help alleviate the significant challenges currently seen in rural areas with access and travel time to receive addiction treatment. [5] [6] [7] [8] Pharmacies are increasingly dispensing medications to treat opioid addiction and overdose, and such approaches have been proposed as promising ways to promote access to effective opioid use disorder treatment and further the integration of addiction treatment across the healthcare system. 21 Although pharmacy organizations around the country have expressed interest in developing new pharmacy services centered on opioid misuse and addiction such as the administration of naltrexone injections, this practice remains relatively rare. 24, 36 Important barriers to pharmacist engagement in these activities may include state pharmacy practice laws, lack of provider recognition at the state or federal level, a lack of integrated support services and administrative support, and low reimbursement.
7,25,37
Limitations
Only treatment facilities classified by SAMHSA as substance abuse treatment facilities were included in the analysis; other facilities (ie, mental health treatment facilities) are not included, even though some of these facilities may provide some substance abuse or opioid treatment services. However, this is likely not a major limitation as many facilities are classified as both substance abuse and mental health treatment facilities. Data on opioid-related overdose deaths is based on information provided on Wisconsin resident death certificates. Underreporting of deaths may have occurred due to the lack of specify of drug involvement on death certificates, as well as variations in diagnosis or reporting. 2 In addition, caution should be used when comparing crude county-level death rates, as they do not take into account underlying differences in the age distribution of the population.
Conclusions
Community pharmacies are ideally located in areas that could be used to support medication-assisted addiction treatment efforts, particularly in rural areas lacking formal substance abuse treatment facilities. Utilizing community pharmacies to provide access to quality opioid addiction and overdose treatments may be a promising approach to rapidly expand addiction treatment in underserved areas.
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